TREA

90011832 - INTELLISEP

Follow

Information

  • Trademark
  • 90011832
  • Serial Number
    90011832
  • Filing Date
    June 19, 2020
    4 years ago
  • Transaction Date
    February 05, 2024
    a year ago
  • Status Date
    June 09, 2023
    a year ago
  • Published for Opposition Date
    October 26, 2021
    3 years ago
  • Location Date
    May 19, 2022
    2 years ago
  • Status Code
    732
  • Current Location
    DIVISIONAL UNIT
    Employee Name
    FOSDICK, GEOFFREY A
  • Attorney Docket Number
    08226
    Attorney Name
    Holly Pranger
    Law Office Assigned Location Code
    M20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
INTELLISEP
Case File Statements
  • GS0441: medical services; medical treatment of sepsis, cancer and immune-mediated diseases; medical analysis services in the fields of cytometry, oncology, and hematology
  • GS0101: medical diagnostic apparatus for analysis of biomarker levels and/or relative expression of host response genes, medical diagnostic apparatus for analyzing gene expression tests using bioinformatics and machine learning algorithms, medical diagnostic apparatus for analyzing gene expression tests, gene expression profiling assays, genetic information, protein biomarkers, clinical data and/or demographic information to aid treatment decisions; sample preparation devices for medical diagnostic purposes in the nature of lysing apparatus in the nature of bd lyse wash assistant, coulter qprep, and related recorded data management software sold as a unit; diagnostic test apparatus for medical use for analysis of gene expression, protein expression, metabolite expression, inflammation, immune- suppression, immune disorders; medical and medical diagnostic apparatus for use in analysis of gene expression tests, analysis of gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing clinical data, and/or analyzing demographic information; point of care medical devices, namely, polymerase chain reaction (pcr) testing equipment for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders; medical devices for use in the treatment of sepsis, cancer and other immune-mediated conditions in the fields of oncology, hematology, and for diagnosis and treatment of sepsis; medical testing kits comprising apparatus for taking blood, apparatus for blood analysis, test tubes, and cartridges for cancer and other immune-mediated conditions; apparatus for diagnostic purposes, namely, medical diagnostic apparatus for testing for cancer and other immune-mediated conditions in the fields of oncology and hematology; automated medical instruments, namely, host-response testing equipment, cytometers which use electronics and optical fluorescence flow cytometry to analyze human cells; ultraviolet visible and near infrared fluorescence analyzers for medical use and components therefor; imaging platforms, namely, medical imaging apparatus for imaging and analysis of cells and cell organelles, molecular diagnostics and imaging cytometry for medical use; medical micro imaging apparatuses for imaging and analysis of bacteriums, viruses, cells and cell organelles for medical use and components therefor; medical micro imaging apparatuses for molecular diagnostics and cytometry for medical diagnostic use and components therefor; medical apparatuses for the examination and analysis of proteins, peptides, antibodies and molecules for medical diagnostic use and components therefor; digital imaging platforms, namely, medical micro imaging apparatus for acquiring and processing microscopic images for medical diagnostic use; digital imaging platforms, namely, medical micro imaging apparatus for use in the examination of cells, proteins and peptides for medical diagnostic use; diagnostic apparatus for medical use, namely, computed tomography scanners, fluorescent microscope systems comprised of optical detection modalities, apparatus in the nature of apparatus for performing complete blood count measurements and measurements of monocyte distribution with magnification objective for use in performing fluorescent antibody technique analysis and fluorescent protein technique analysis; diagnostic apparatus for medical use, namely, automatic cell sorting systems comprised of apparatus for performing single-cell analysis, optical detection modalities apparatus in the nature of optical measurement equipment, electrical detection modalities apparatus for medical diagnostic purposes, mechanical detection modalities apparatus for determining lateral displacement for medical diagnostic purposes; flow cytometers for use in flow cytometry analysis and in fluorescence activated cell sorting for medical diagnostic purposes; flow cytometers
Case File Event Statements
  • 6/10/2023 - a year ago
    40 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/9/2023 - a year ago
    39 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 6/8/2023 - a year ago
    38 - SOU EXTENSION 3 FILED Type: EXT3
  • 6/8/2023 - a year ago
    37 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/17/2023 - 2 years ago
    36 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/15/2022 - 2 years ago
    35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/14/2022 - 2 years ago
    34 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 12/12/2022 - 2 years ago
    33 - SOU EXTENSION 2 FILED Type: EXT2
  • 12/12/2022 - 2 years ago
    32 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/20/2022 - 2 years ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/19/2022 - 2 years ago
    30 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 5/9/2022 - 2 years ago
    29 - SOU EXTENSION 1 FILED Type: EXT1
  • 5/19/2022 - 2 years ago
    28 - DIVISIONAL PROCESSING COMPLETE Type: DPCC
  • 5/2/2022 - 2 years ago
    27 - DIVISIONAL REQUEST RECEIVED Type: DRRR
  • 5/2/2022 - 2 years ago
    26 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD
  • 5/14/2022 - 2 years ago
    25 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 5/9/2022 - 2 years ago
    24 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/2/2022 - 2 years ago
    23 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 12/21/2021 - 3 years ago
    22 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 10/26/2021 - 3 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/26/2021 - 3 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/6/2021 - 3 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/21/2021 - 3 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/21/2021 - 3 years ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 9/21/2021 - 3 years ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 9/21/2021 - 3 years ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 9/21/2021 - 3 years ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/29/2021 - 3 years ago
    13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/29/2021 - 3 years ago
    12 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/29/2021 - 3 years ago
    11 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/23/2021 - 4 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/23/2021 - 4 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/22/2021 - 4 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 11/18/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/15/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/15/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/15/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/9/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/17/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/23/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP